AMP Capital Investors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,032
| Closed | -$1.73M | – | 712 |
|
|
2021
Q3 | $1.73M | Sell |
18,032
-1,484
| -8% | -$142K | 0.01% | 759 |
|
|
2021
Q2 | $1.9M | Sell |
19,516
-12,495
| -39% | -$1.22M | 0.01% | 757 |
|
|
2021
Q1 | $3.1M | Buy |
32,011
+12,076
| +61% | +$1.17M | 0.02% | 707 |
|
|
2020
Q4 | $1.9M | Buy |
19,935
+362
| +2% | +$34.5K | 0.01% | 760 |
|
|
2020
Q3 | $1.91M | Buy |
19,573
+2,550
| +15% | +$249K | 0.01% | 726 |
|
|
2020
Q2 | $2.14M | Buy |
17,023
+2,993
| +21% | +$376K | 0.01% | 685 |
|
|
2020
Q1 | $1.29M | Hold |
14,030
| – | – | 0.01% | 734 |
|
|
2019
Q4 | $1.5M | Buy |
+14,030
| New | +$1.5M | 0.01% | 802 |
|
|
2014
Q1 | – | Sell |
-17,497
| Closed | -$165K | – | 1236 |
|
|
2013
Q4 | $165K | Hold |
17,497
| – | – | ﹤0.01% | 1193 |
|
|
2013
Q3 | $200K | Buy |
+17,497
| New | +$200K | ﹤0.01% | 1141 |
|